The new system developed by Professor Chad Mirkin delivers CRISPR machinery more safely and effectively into cells.

Dr. Musunuru and Dr. Ahrens-Nicklas holding KJ post infusion Senior Correspondent Gene therapy has always held enormous promise to correct genetic diseases, but turning that potential into treatments ...

CRISPR was one of the most influential breakthroughs of the last decade, but it's still imperfect. While the gene editing tool is already helping people with genetic ailments, scientists are also ...

This little company's scientific breakthrough opened up a whole new sliver of the drug market (although it's still leading ...

Expertise from Forbes Councils members, operated under license. Opinions expressed are those of the author. In the world of biopharmaceutical innovation, 2024 will be remembered as CRISPR’s breakout ...

Edits create cells that don’t trigger an immune response, allowing implant recipient to forego immune-suppressing drugs.

CRISPR stock offers bold investment potential and how strategic portfolio management can boost resilience and long-term ...

CRISPR Therapeutics has reported reductions in triglycerides and LDL cholesterol of more than 80% after a single dose of its in vivo liver editing prospect CTX310, encouraging the company to forge ...

Using the gene scissors CRISPR and stem cells, researchers at Stockholm University and the UK Dementia Research Institute (UK DRI) at King's College London have managed to identify a common ...

Scientists have achieved the first DNA-free CRISPR gene editing in raspberries, reaching 19% efficiency and opening the door to faster breeding of firmer, more resilient berries — though regenerating ...

It has long been understood that orchard automation is the key for industry’s profitability and sustainability. As part of ...